Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of BIOF will - over the next 2 Weeks and hit - by . In that time frame, BIOF's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
BIOF shares rose +11.04% in Friday, September 4, 2026's trading session, rising from a previous close of $0.10 to move at $0.11. The stock demonstrated notable intraday movement (see BIOF's key stats for a full breakdown), fluctuating between $0.10 and $0.11, a +6.05% trading range. While recent weeks have seen some volatility, BIOF has managed to secure a +7.00% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 433.9K shares changing hands, 203.9K more than the previous session. This amounted to $46.43K in total market activity.
Will BIOF Continue Its Trend?
According to analyst ratings and projections for BIOF, Blue Biofuels, Inc. shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators for BIOF currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 16 negative trading days within the past 30 sessions. Based on the BIOF stock forecast, now is not the best time to buy BIOF stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on BIOF covering social and institutional perspectives.
BIOF Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into BIOF's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 49.47% to 55.56%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 45.20%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 45.73%, maintains a neutral outlook for the long term. Insights into BIOF's shareholder base show how institutional investors are positioning themselves during these momentum shifts

